Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Combo Treatment Extends Kidney Cancer Survival


Related Encyclopedia
 border=
Bashful Bladder Syndrome
Kidney Dialysis
Kidney Diseases
Kidney Infection
More...

Related Healthscout Videos
 border=
Getting Off Dialysis For Good!
Getting Off Dialysis for Good!
SURVIVING LONGER WITH KIDNEY CANCER
Dialysis At Home
More...

Related News Articles
 border=
FDA Puts Black-Box Warning on Bowel-Cleansing Drugs
Report Confirms Source of Contaminated Heparin
U.S. Cancer Rate-Death Rate Combo Drops for 1st Time
Cancer Drug Ups Risk of Clots in Veins
More...


Page:  << Prev | 1 | 2

"This can result in better survival and better quality of life for survivors. On the other hand, with more and more drugs and combinations, it may become harder to see the impact of an individual drug," he added.

Another expert lauded the paper.

"This article provides another outstanding example of how a greater understanding of the biology of kidney cancer can lead to successful treatments that delay tumor growth," said Dr. James Brugarolas, an assistant professor in the division of oncology at the Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center at Dallas.

Text Continues Below



"An important question that remains to be addressed is whether bevacizumab alone would offer similar benefit with respect to slowing down tumor progression as the bevacizumab/interferon combination, with perhaps less toxicity," Brugarolas said.

More information

For more on kidney cancer, visit the U.S. National Cancer Institute.

Page:  << Prev | 1 | 2

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 12/21/2007

Related Links
 border=
From Healthscout's partner site on incontinence, IncontinenceNetwork.com
Learn about urinary incontinence types, treatments, and more.
Get information about stress incontinence.
What is different about urge incontinence?





SOURCES: Mayer Fishman, M.D., Ph.D., assistant professor, department of interdisciplinary oncology, Moffitt Cancer Center, University of South Florida, Tampa; James Brugarolas, M.D., Ph.D., assistant professor, division of oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas; Dec. 22/29, 2007, The Lancet


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map